Wedbush Securities Inc Catalyst Biosciences, Inc. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$4.55 - $7.29 $104,568 - $167,538
-22,982 Closed
0 $0
Q3 2020

Oct 20, 2020
BUY
$4.22 - $6.04 $96,984 - $138,811
22,982 New
22,982 $99,000
Q4 2019

Jan 16, 2020
SELL
$4.52 - $7.91 $91,846 - $160,731
-20,320 Closed
0 $0
Q3 2019

Oct 17, 2019
BUY
$4.91 - $9.31 $99,771 - $189,179
20,320 New
20,320 $100,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email